Latest News

News
Roche and VinCense Join Forces to Combat Diabetes Epidemic in Tamil Nadu
24-04-2024
News
Nanavati Max Super Speciality Hospital Commemorates World Liver Day with Inspirational Walk-a-thon
23-04-2024
News
ENTOD Pharmaceuticals Introduces PresVu Eye Drops to Combat Presbyopia
23-04-2024
News
FDA-Approved CoolSculpting Revolutionizes Non-Surgical Fat Reduction for Morbidly Obese Patients
22-04-2024
News
Mac-Chem Products (India) Pvt. Ltd’s Boisar Facility Renews EU-GMP Certification, Pledges Continued Commitment to Global Pharma Standards
22-04-2024
News
AIIMS Bhopal Holds Swarna Prashan Ceremony to Enhance Children's Health
22-04-2024
Corporate Update

Sun Pharma hits record high By eHealth Network - 04 July 2014

Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories are trading higher by 2 percent.

Sun Pharma stock surged 2 percent to Rs 707, while Ranbaxy Laboratories gained 2 percent to Rs 534.


USFDA has granted approval to Ranbaxy’s subsidiary Ohm Laboratories to manufacture and sell generic Diovan in the US.

Source: IIFL



Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Tags: BSE Sensex Business/Finance Diovan Economy of India food and drug administration Health/Medical/Pharmaceuticals India Infoline OHM LABORATORIES INC. Pharmaceutical industry Pharmaceutical sciences Pharmacology Ranbaxy Laboratories RANBAXY LABORATORIES LTD Sun Pharma Sun Pharmaceutical SUN PHARMACEUTICAL INDUSTRIES LIMITED Technology/Internet United States

Related Corporate Updates

whatsapp--v1